Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Argyle Resources Corp. Announces Closing of First Tranche of Private Placement Offering
Argyle Resources Corp. Announces Closing of First Tranche of Private Placement Offering

Vancouver, B.C., February 18th, 2025Argyle Resources Corp. (CSE: ARGL) (OTCQB: ARLYF) (FSE: ME0) (“Argyle” or the “Company“) is pleased to announce that it has closed a first tranche of

Primary Unveils 2025 Exploration Plan to Advance Natural Hydrogen Discovery
Primary Unveils 2025 Exploration Plan to Advance Natural Hydrogen Discovery

Vancouver, British Columbia – February 18, 2025 – Primary Hydrogen Corp. (TSXV: HDRO, FRA: 83W0, OTCQB: HNATF) (the “Company” or “Primary”), a leading exploration company focused on

IsoEnergy and Future Fuels Complete Transaction Related to Mountain Lake Property in Nunavut
IsoEnergy and Future Fuels Complete Transaction Related to Mountain Lake Property in Nunavut

VANCOUVER, B.C., February 18, 2025 – IsoEnergy Ltd. (TSX: ISO) (OTCQX : ISENF) (“IsoEnergy”) https://www.commodity-tv.com/ondemand/companies/profil/isoenergy-ltd/ - and Future Fuels Inc.

HYTN and A1 Cannabis Announce Collaboration Agreements to Scale Production of Cannabis Products
HYTN and A1 Cannabis Announce Collaboration Agreements to Scale Production of Cannabis Products

Vancouver, British Columbia – February 17, 2025 – HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a company specializing in pharmaceutical-grade

Realbotix Releases Robotic AI Vision System
Realbotix Releases Robotic AI Vision System

LAS VEGAS, NEVADA, February 17, 2025 / IRW-Press / Realbotix Corp. (TSX-V: XBOT) (Frankfurt Stock Exchange: 76M0.F) (OTC: XBOTF) (“Realbotix” or the “Company”), a leading creator of humanoid

Positive Phase II Data from Clinical Trial of RECCE® 327 Gel Supports Accelerated Commercialisation Pathway
Positive Phase II Data from Clinical Trial of RECCE® 327 Gel Supports Accelerated Commercialisation Pathway

Highlights:

 

-          Successful Phase II clinical trial assessing efficacy and safety of RECCE® 327 topical gel (R327G) in patients with Acute Bacterial Skin and Skin Structure Infections

Forge Resources Announces Closing Of Signifcantly Oversubscribed Private Placement
Forge Resources Announces Closing Of Signifcantly Oversubscribed Private Placement

Vancouver, British Columbia (February 4, 2025) – Forge Resources Corp. (CSE: FRG; OTCQB: FRGGF; FFSE: 5YZ) ("FRG" or the "Company") is pleased to announce the closing of its significantly

Forge Resources Corp Announces Significant Progress of Portal Construction at Fully Permitted La Estrella Coal Mine, Colombia and Hiring of Mining Engineer Emilio Gene
Forge Resources Corp Announces Significant Progress of Portal Construction at Fully Permitted La Estrella Coal Mine, Colombia and Hiring of Mining Engineer Emilio Gene

Vancouver, British Columbia (February 4, 2025) - Forge Resources Corp. (CSE: FRG; OTCQB: FRGGF; FFSE: 5YZ) ("FRG" or the "Company") is pleased to announce the closing of its significantly

dynaCERT Announces $5,000,000 Non-Brokered Listed Issuer Financing Equity Offering
dynaCERT Announces $5,000,000 Non-Brokered Listed Issuer Financing Equity Offering
dynaCERT - Press Release (LIFE exemption Unit Offering) (00768411-3).DOCX

TORONTO, ON--( February 14, 2025) dynaCERT Inc. (TSX: DYA) (OTC: DYFSF) (FRA: DMJ) ("dynaCERT" or the "Company") is

Onco-Innovations' Nanoparticle Formulation PNKP Technology Combined with Radiation Therapy, and as a Standalone Treatment, Shown in Studies to Slow Colorectal Cancer Tumour Growth
Onco-Innovations' Nanoparticle Formulation PNKP Technology Combined with Radiation Therapy, and as a Standalone Treatment, Shown in Studies to Slow Colorectal Cancer Tumour Growth
Green Bridge Metals Corporation Options World Class Copper-Nickel Exploration portfolio in Duluth Complex Minnesota

Vancouver, Canada - February 14, 2025 - Onco-Innovations Limited (CSE: ONCO

Anixa Biosciences Chairman and CEO Discusses Pioneering CAR-T Cell Therapy and Breast Cancer Vaccine in Alpha Wolf Trading Interview
Anixa Biosciences Chairman and CEO Discusses Pioneering CAR-T Cell Therapy and Breast Cancer Vaccine in Alpha Wolf Trading Interview

SAN JOSE, Calif., Febaruary 14, 2025 – Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today

Spanish Mountain Gold announces new power line to site is advancing
Spanish Mountain Gold announces new power line to site is advancing

This news release is not for distribution to U.S. newswire services for dissemination in the United States.

 

Vancouver, BC January 20, 2025Spanish Mountain Gold Ltd. (the "Company" or "